FDA Approves Wegovy: First Oral Weight-Loss Pill

The U.S. FDA has approved Wegovy, the first oral medication for weight loss developed by Novo Nordisk. This significant advancement in obesity treatment offers patients a needle-free option with an average weight reduction of 16.6%. The approval positions Novo Nordisk favorably in the competitive weight-loss market, providing a new solution for those seeking to manage their weight effectively.